Bruker Corp. | Balance Sheet

Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
439
499
468
500
439
322
Total Accounts Receivable
308
293
235
244
319
383
Inventories
590
477
422
440
486
510
Other Current Assets
96
96
107
91
114
89
Total Current Assets
1,432
1,366
1,232
1,276
1,359
1,304
Net Property, Plant & Equipment
300
250
231
239
267
271
Total Investments and Advances
-
3
-
-
-
-
Intangible Assets
233
212
205
200
252
494
Other Assets
5
4
9
17
15
8
Total Assets
1,988
1,865
1,730
1,808
1,949
2,129
ST Debt & Current Portion LT Debt
1
1
1
20
-
Accounts Payable
75
76
72
86
91
Income Tax Payable
26
34
25
11
28
Other Current Liabilities
547
471
457
407
406
Total Current Liabilities
649
583
555
525
525
Long-Term Debt
354
354
265
392
416
Provision for Risks & Charges
41
66
92
103
106
Deferred Taxes
4
12
44
66
33
Other Liabilities
72
72
76
86
145
Total Liabilities
1,138
1,093
997
1,115
1,215
Common Equity (Total)
846
766
726
686
725
Total Shareholders' Equity
846
766
726
686
725
Total Equity
850
772
733
693
734
Liabilities & Shareholders' Equity
1,988
1,865
1,730
1,808
1,949
Accumulated Minority Interest
4
6
7
7
8

About Bruker

View Profile
Address
40 Manning Road
Billerica Massachusetts 01821
United States
Employees -
Website http://www.bruker.com
Updated 07/08/2019
Bruker Corp. engages in the development, manufacture and distribution of scientific instruments, and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. It operates through the Bruker Scientific Instruments (BSI) and Bruker Energy and Supercon Technologies (BEST) segments. The BSI segment is comprised of the Bruker BioSpin Group, the Bruker CALID Group, and the Bruker Nano Group.